Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 02, 2021

SELL
$48.42 - $60.18 $116,740 - $145,093
-2,411 Closed
0 $0
Q2 2019

Aug 16, 2019

SELL
$37.28 - $41.68 $48,724 - $54,475
-1,307 Reduced 35.15%
2,411 $100,000
Q4 2018

Feb 14, 2019

BUY
$36.86 - $41.49 $137,045 - $154,259
3,718 New
3,718 $141,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $247B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Human Investing LLC Portfolio

Follow Human Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Human Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Human Investing LLC with notifications on news.